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Background
In developmental age migraine is a very common neurolo-
gical disorder, but very few drugs are disposable. Aim of
study is comparing the middle term effect of two nutraceti-
cal complexes on frequency, disability grade and intensity
of migraine in a paediatric sample.
Materials and methods
One complex composed by Ginkgolide B/Coenzyme Q10/
Riboflavin/Magnesium (complex A) was oral administered
as prophylactic therapy twice a day for 6 months to 187
school-aged patients and other one composed by the asso-
ciation of L-triptophan/5hydrossitriptophan (Griffonia
simplicifolia)/vitamin PP/vitamina B6 (complex B) to
other 187 children with MoA, matched for age (p=0.575)
and sex distribution (p=0.918). Each patient kept a journal
to record: number and intensity of attacks and concomi-
tant symptoms. To assess the intensity, disability grade
and behavioural variations linked to migraine a visual ana-
logue scale (VAS), the PedMIDAS scale and a behavioural
scale were administered at the beginning and at the end of
treatment.
Results
Our Results show that the two nutraceutical complexes
can reduce all the disabilities aspects of migraine in our
samples and the effects of Complex A after six months of
treatment seem to have more efficacy than Complex B
(Delta% frequency p<0.001, Delta% duration p<0.001,
Delta% PedMIDAS p<0.001, Delta% VAS p¡Ü0.001), also
for the behavioural aspects (Delta% Behaviour p¡Ü0.001,)
that are very important for the dynamics within the family
of migraineurs patients, suggesting its improved therapeu-
tic effect in the middle-long term.
Conclusion
Our findings also suggest that in childhood headache
management, the use of alternative treatments could be
considered as soft therapy without adverse reactions
even in the middle-long term treatment.
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